Clinical Trials Logo

Cerebral Embolism clinical trials

View clinical trials related to Cerebral Embolism.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03802760 Completed - Cerebral Embolism Clinical Trials

Cerebral Microembolism in Cardiology

ZEMEK
Start date: October 24, 2018
Phase:
Study type: Observational

During different interventional cardiology procedures we aim to identify cerebral microemboli load. Further we aim to differentiate the quality and the quantity of cerebral microemboli.We will measure cerebral microemboli in different interventional phases, e.g. during valve deployment, rapid pacing, post-implantation.

NCT ID: NCT02378116 Completed - Stroke Clinical Trials

Left Atrial Appendage Closure During Open Heart Surgery

LAACS
Start date: October 2011
Phase: N/A
Study type: Interventional

Because atrial fibrillation occurs frequently in heart surgery patients, our overall hypothesis is that systematic closing the left atrial appendage during surgery will reduce cerebral embolism coming from the thrombus formation in the left atrium. The specific hypothesis which sought tested is that closure of the left atrial appendage in connection with elective CABG and / or valve surgery will lead to fewer strokes and micro cerebral infarcts measured by MRI.

NCT ID: NCT02021045 Completed - Clinical trials for Complication of Dialysis

Cerebral Microembolism During Hemodialysis

Start date: September 2013
Phase: N/A
Study type: Observational

There is increasing evidence that renal replacement therapy (= continuous veno-venous hemodialysis) generates cerebral microembolism which is detectable on transcranial Doppler ultrasound. The aim of this study is to monitor patients with transcranial Doppler under two conditions: during hemodialysis and in a hemodialysis-free interval (in each period cerebral embolic load is detected during 30 minutes). The study hypothesis is that during hemodialysis the cerebral embolic load is significantly higher than in the hemodialysis-free interval.

NCT ID: NCT01028794 Completed - Stroke Clinical Trials

Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients

Start date: May 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether autologous bone marrow mononuclear cells transplantation after stroke is safe and/or effective to improve neurological outcome.